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Abstract
Background: A couple’s decision to undergo an invasive test based on a screening test result is a process
associated with anxiety. The aim of this study was to determine whether anxiety and prenatal attachment were
affected by undergoing an invasive test compared to women in early pregnancy and after a reassuring anomaly
scan.
Methods: 200 women were recruited at booking, 14 women and 20 partners after an invasive test and 81 women
following an anomaly scan. A questionnaire was completed using the Beck Anxiety Inventory and Maternal or
Paternal Antenatal Attachment Scales.
Results: Women who have had an invasive test have higher levels of anxiety compared to women at booking (P
< 0.01) and after an anomaly scan (P = 0.002). Anxiety declines from booking to the time of an anomaly scan (P =
0.025), whilst attachment increases (P < 0.001). There is a positive correlation between anxiety and attachment in
women who have had an invasive test (r = 0.479). Partners of women undergoing an invasive test experience
lower levels of anxiety (P < 0.05).
Conclusions: Women undergoing prenatal diagnostic procedures experience more psychological distress, which
may be currently underestimated. Establishment of interdisciplinary treatment settings where access to
psychological support is facilitated may be beneficial.
Background
Prenatal screening for chromosomal abnormalities such
as Down’s syndrome is offered to all pregnant women in
the United Kingdom as part of routine antenatal care.
This initial screening process provides the mother-to-be
and her partner with an estimation of the risk that their
child may have an abnormality. The decision to undergo
f u r t h e rm o r ei n v a s i v ed i a g n o s t i ct e s t sb a s e do nt h i s
probability then rests with the couple. The process of
making this decision is associated with increased anxiety
and stress for the pregnant woman and her partner.
The levels of stress and anxiety may be influenced by
the information given, the counselling and psychological
support provided, the results of the prenatal tests, and
the outcome of the pregnancy. Stress and anxiety may
also affect maternal feelings of attachment towards the
fetus, and it is plausible that appropriate care and sup-
port may positively influence feto-maternal attachment
by minimising stress.
Anxiety in Pregnancy
Anxiety is defined as the psychological consequence of
exposure to a real or imagined stress [1]. The decision
to undergo a prenatal invasive test is undoubtedly asso-
ciated with anxiety. There is much debate surrounding
prenatal invasive testing asam e a n so fr e a s s u r a n c ef o r
women identified as being at risk of carrying a fetus
affected by a chromosomal or structural abnormality.
While undergoing prenatal screening for genetic
abnormalities may protect women from high levels of
anxiety [2,3], it may also encourage women to focus on
what may be wrong with the child, increasing levels of
anxiety [4].
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between undergoing an invasive test and increased anxi-
ety levels [2,5,6] although receiving a normal result may
in fact reduce the anxiety experienced later in the preg-
nancy [3].
Studies of prenatal anxiety and stress are important
because there is increasing evidence that prenatal anxi-
ety and stress may have long-term sequelae for both the
pregnant woman and her fetus [7-9]. The mechanism by
which these adverse effects occur is poorly understood
but animal studies have shown that chronic stress may
downregulate the fetal cortisol barrier enzyme response
resulting in enhanced exposure of the fetus to maternal
cortisol levels [10]. Abnormally high placental cortico-
tropin releasing hormone (CRH) levels can cause vasodi-
latation resulting in reduced oxygen and nutrient
delivery to the fetus [11]. Prolonged suboptimal condi-
tions may lead to a state of ‘thrifty’ metabolism [12] pre-
disposing to type II diabetes and obesity in later life
[13]. If this physiological fetal programming occurs at a
stage when the fetus is particularly sensitive to stressors
there may be long-lasting impact upon memory, learn-
ing, affect and even frontal lobe executive function [9].
A study by Uno et al found that animals treated with
synthetic glucocorticoids prenatally were shown to have
a 30% reduction in hippocampal size [14].
Furthermore, stimulation of the autonomic nervous
system (ANS) by anxiety or stress may lead to increased
release of catecholamines such as noradrenaline, increas-
ing uterine artery resistance and arterial pressure, caus-
ing a decrease in uterine blood flow and thus oxygen
delivery to the fetus. One study found that high nora-
drenaline levels in pregnancy were negatively correlated
to fetal head and abdominal circumferences [15].
Prenatal Attachment
Any doubts raised concerning the health of the fetus
that may lead to increased levels of stress and anxiety,
such as a positive screening result or prenatal invasive
test, may also interrupt the normal development of the
psychological bond between the other and her fetus,
which could lead to abuse, neglect and the ill-health of
the child.
Feto-maternal attachment was described by Muller as
‘the unique and affectionate antenatal relationship that
develops between a mother and fetus’ and it is charac-
terised by the behaviours, attitudes, thoughts and feel-
ings that demonstrate care and commitment to the fetus
[16,17]. There is little previous research into prenatal
attachment in women undergoing screening or an inva-
sive diagnostic test in pregnancy. One study, using the
Pregnancy Involvement List (PIL) to measure attach-
ment, found that offering screening to women tempora-
rily increases attachment [18] but another showed that
undergoing a prenatal invasive test may decrease prena-
tal attachment, assessed using the Prenatal Attachment
Interview (PAI) [19].
Two small studies have suggested that men have lower
anxiety levels than their partners at the time of a prena-
tal invasive test [20,21] but did not report on paternal
attachment.
Purpose of the Study
This study aims to compare the relationship between
anxiety and attachment in women and their partners
undergoing an invasive test to women at an early gesta-
tion (who have not yet had any screening) and women at
about 20 weeks gestation whose fetal morphology scan
has shown no apparent abnormalities.
Methods
Pregnant women and their partners attending the Jessop
Wing, Royal Hallamshire Hospital, Sheffield were asked
to participate between November 2009 and May 2010.
Ethical Approval
The design of the study was given a favourable ethical
opinion by the South Yorkshire Research Ethics Commit-
tee (reference number 09/H1310/64). Patients and their
partners were asked to sign three copies of a consent
form - one to be kept in the patients’ medical records,
one for the patient or partner to keep for reference and
one for the researcher.
Subjects
Three groups of pregnant women were recruited into the
study along with one group of partners. Participants were
excluded from the study if they had a current or past
history of depression, anxiety or a significant medical
condition that requires medication. Women with vaginal
bleeding in the past two weeks or women who had suf-
fered a previous miscarriage or had a family history of
genetic disorder were also excluded.
The Q1 group were women recruited at booking - up
to 18 weeks gestation - before they had any screening
for Down’s syndrome. Of 307 women approached, 107
were excluded whilst 200 women were recruited.
The Q2 group consisted of women who attended the
feto-maternal unit and opted for an invasive genetic test
following a screen-positive prenatal test for Down’ss y n -
drome or at the request of the pregnant woman due to
maternal age. These women were between 12 and 18
weeks in gestation. Men who accompanied their spouses
to this appointment were also recruited. Of 30 women
and 24 partners who agreed to participate, 16 women
and 4 men were excluded. Hence 14 women and 20 part-
ners were included in the invasive test group. In total
11 couples were included.
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who were screen-negative for Down’ss y n d r o m ea n d
were recruited following a routine detailed scan at 18 to
22 weeks gestation that identified no major fetal
abnormalities. 101 women were recruited in this group,
of which 20 were excluded. Hence 81 women were
included in the anomaly scan group.
Measures
Anxiety and stress were assessed using the Beck Anxiety
Inventory (BAI) [22]. The inventory consists of 21 items
descriptive of subjective, somatic, or panic-related symp-
toms of anxiety. Self-reported answers are based on a 4-
point Likert scale ranging from responses of ‘n o ta ta l l ’
to ‘severe’ in terms of the experience of that symptom
over the past month. A high total score indicates more
severe levels of anxiety.
Attachment was measured using the Maternal Antena-
tal Attachment Scale (MAAS) [23]. The scale consists of
two factors - ‘quality of attachment’ which represents
the quality of a mother’s affective experiences such as
closeness and tenderness; and ‘time spent in attachment
mode’ which represents the intensity of preoccupation a
mother experiences assessed through 19 items based on
the feelings, behaviours and attitudes towards the fetus.
The items are rated on a 5-point Likert scale. The total
attachment score is computed by combining the two
subscales. High scores reflect a positive quality of
attachment. The paternal version of MAAS - the Pater-
nal Antenatal Attachment Scale (PAAS) - consists of 16
items.
Survey Instruments
Each participant was administered a survey instrument
that included basic demographic information such as age,
ethnicity, annual income, obstetric history, marital status
and education; a scale for the assessment of anxiety and
a scale for the assessment of prenatal attachment. They
were asked to either complete the questionnaire while
they waited or to post it back using the freepost envelope
provided. Addtional file 1 gives an example of one of the
questionnaires.
Analyses
Data was entered into and analysed using SPSS 16.0
(Statistical Package for Social Science, Inc., Chicago, IL)
for Windows. We compared maternal attachment and
anxiety scales between the three groups using descrip-
tive statistics, analysis of variance, T-tests and Mann-
Whitney U tests as were appropriate.
We also employed multiple regression analysis, adjust-
ing for the potential confounding effects of maternal age
and parity on anxiety and attachment scores. Paternal
data was described and anxiety compared with women
in the invasive test group.
Results
Demographics
Table 1 shows the demographics of the women included
in the booking (Q1), invasive test (Q2) and anomaly scan
(Q3) groups.
Participants in Q2 were older than women in the Q1
and Q3 (P < 0.001). 15 women in Q1 (7.5%), 1 woman
in Q2 (7.1%) and 6 women in Q3 (7.4%) were current
smokers with a range of 1 - 20 cigarettes smoked a day.
Anxiety
The mean total score on the BAI was 8.34 for Q1 (SD:
7.47) ranging from 0 - 41; 12.36 for Q2 (SD: 4.47) ran-
ging from 4 - 20; and 8.19 for Q3 (SD: 7.43) ranging
from 0 - 43. The invasive test group (Q2) had signifi-
cantly higher levels of anxiety compared to the booking
(P = 0.003) and anomaly scan groups (P = 0.002). This
can be shown graphically in Figure 1f.
If we classify levels of anxiety, a score of 0-7 indicates
minimal anxiety; 8-15 indicates mild anxiety; 16-25 indi-
cates moderate anxiety and a score of 26 and above
indicates severe anxiety [22]. Women in Q2 experienced
more severe anxiety, albeit within the ‘minimal’ range,
on average (mean: 2.29; SD: 0.79 vs. mean: 1.56; SD:
0.61 for Q1 and mean: 1.54; SD: 0.82 for Q3) but with
35.7% (n = 5) experiencing moderate anxiety.
Attachment
Table 2 shows the mean total MAAS scores by group.
Higher levels of attachment were experienced by women
of increasing gestation (Q1 vs. Q3 P < 0.001). Using the
cut-off scores employed by Pollock and Percy in
Table 1 clinical characteristics of women at booking,
undergoing an invasive test and after an anomaly scan.
Booking
Group
(Q1)
n = 200
Invasive
Test
Group (Q2)
n=1 4
Anomaly
Scan
Group (Q3)
n=8 1
Maternal age (years) 30.4 (5.1) 36.7 (5.8) 30.0 (5.5)
Gestation (weeks) 12 [8-18] 13.5 [11-21] 20 [18-27]
Gravidity 1 [1-7] 1.5 [1-6) 1 [0-7]
Parity 0 [0-5] 0 [0-5] 0 [0-4]
Ethnicity: White
British
81.5% 78.6% 77.8%
Education: Further 76.0% 71.4% 80.2%
Marital Status:
Married
60.0% 14.3% 66.7%
Employed: Yes 78.5% 71.4% 76.5%
Data are shown as mean (SD) or median [range].
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categorised into ‘high’ (a score of seventy-six and above)
and ‘low’ [24,25]. Given these categories, the further
along a woman was in her pregnancy, the ‘higher’ her
attachment was. 49% of women in Q1 had ‘high’ attach-
ment compared to 64.2% of women in Q3 (P = 0.021).
Looking independently at the subscales of MAAS,
16.5% of women in Q1, 14.3% of women in Q2 and
33.3% of women in Q3 had a ‘positive’ quality of attach-
ment (scoring 49 or above) suggesting that quality of
attachment increases throughout pregnancy (Q1 vs. Q3
P = 0.002).
In terms of intensity of preoccupation with their
babies, 42.5% of women in Q1, 57.1% of women in Q2
and 53.1% of women in Q3 were ‘preoccupied’ (scoring
27 or above) rather than ‘disinterested’.
Figure 2 shows that moderate positive correlation was
found between anxiety and prenatal attachment in
women in the invasive test group (r = 0.479, n = 14, P =
0.083) with the variables sharing 23% of their variance.
No such correlation was demonstrated for women in
Q1 and Q3.
Table 3 shows the anxiety scores for women in each
group by attachment subscales. Women who had a
‘negative’ quality of attachment and were more ‘preoccu-
pied’ with their pregnancy had higher levels of anxiety.
There was a statistically significant difference in the pro-
portion of women in Q2 who had ‘high’ attachment
experiencing higher levels of anxiety (mean: 13.86; SD:
3.85) compared to Q1 (mean: 9.11; SD: 7.97; P = 0.015)
and Q3 (mean: 8.48; SD: 7.35; P = 0.004). Women in
Q2 who had a ‘negative’ quality of attachment or were
‘preoccupied’ with their pregnancy were also more likely
to experience higher levels of anxiety than any other
group (P < 0.05).
Eight women were recruited on more than one occa-
sion (into two groups of the study) allowing for longitu-
dinal analyses. For the five women recruited into Q1
and Q3, anxiety decreased over time (P = 0.025) and
attachment increased (P < 0.001). For the three women
recruited into Q1 and Q2, anxiety levels appeared to
dramatically increase after undergoing an invasive test
and attachment levels appeared to fall but due to the
small sample size these results were not statistically
significant.
Paternal Data
The mean total BAI score for partners included in Q2
was 8.20 (SD: 7.13), with scores ranging from 0 - 27.
This is less than women included in this group suggest-
ing that men experience lower levels of anxiety than
their partners who have recently undergone an invasive
test (P = 0.036).
The mean total PAAS score for partners included in
Q2 was 54.05 (SD: 9.34), with scores ranging from 35 -
68. This represents mean % scores of the total maximum
Figure 1 Distribution of total anxiety scores between groups;
the mean anxiety score is higher for Q2 than the other two
cohorts.
Table 2 total BAI and MAAS scores by group.
Booking
Group
(Q1)
n = 200
Invasive Test
Group
(Q2)
n=1 4
Anomaly Scan
Group
(Q3)
n=8 1
Total BAI score 8.3 (7.5) 12.4 (4.5) 8.2 (7.4)
Total MAAS
score
74.7 (7.1) 75.2 (7.1) 78.5 (7.1)
Data are shown as mean (SD).
Figure 2 Correlation between total BAI and MAAS scores in
Q2; there is moderate positive correlation between the two
variables.
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women scores of 79.2% (75.2/95).
For the 11 couples included in Q2, pregnant women
experienced considerably higher levels of anxiety than
their partners (mean: 13.55; SD: 3.93 vs. mean: 6.36; SD:
8.06; P = 0.015).
Discussion
This study shows that women who have recently under-
gone an invasive test have higher levels of anxiety com-
pared to women at earlier gestations first attending for
antenatal care, and to women at a later gestation in
mid-trimester immediately following a reassuring fetal
morphology scan. This is consistent with findings from
previous studies [5,6,26,27]. In a study with a longitudi-
nal design Marteau et al found that anxiety levels in this
group of women later fell to lower levels compared to
other women, illustrating the long-term reassurance
such a procedure may offer. This observation is likely to
represent a normal response to the stress of making a
difficult and risky decision and may aid effective deci-
sion-making.
Maternal stress has been shown to have severe effects
on fetal brain development. Prenatal stress exposure
during the development of the hippocampus, the com-
ponent of the brain responsible for spatial memory tasks
and associative and procedural memory, has been
shown to decrease formation of synapses by at least 30%
[28]. Offspring exposed to prenatal stress also show
decreased numbers of glucocorticoid messenger ribonu-
cleic acid (mRNA) and increased levels of corticotropin-
releasing hormone (CRH) expression in the amygdala
[7,8]. These changes may lead to a predisposition to
mental health disorders such as depression as well as an
increased sensitivity to stressful situation with a pro-
longed recovery and difficulties regulating emotions [9].
Indeed Van der Bergh found that prenatal anxiety in the
third trimester of pregnancy was positively correlated
with a difficult temperament in infants at 10 weeks and
7 months of age [29].
Prenatal stress has also been shown to affect beha-
vioural development, thymic function and immune func-
tion in animal studies. Rhesus monkeys that were
prenatally stressed have been shown to have lower
amounts of exploratory behaviour and significantly more
disturbance behaviour compared to controls [30]. Rats
subjected to synthetic glucocorticoids prenatally showed
a decrease in number of thymic T cells postnatal [31].
The effect of stress and its’ associated immune changes
in pregnancy may be a major factor in preterm labour.
Two hypotheses have been put forward - firstly, that pre-
term birth may occur due to the significant immunologi-
cal changes that occur as a result of stress without
subsequent infection [32] and secondly, that preterm
birth occurs through increased susceptibility to infections
[33].
Stress has also been shown to decrease levels of the
pregnancy supporting hormone progesterone and pro-
gesterone induces blocking factor (PIBF) which up regu-
lates the production of Th1 cytokines [13,34]. This leads
to increased prostaglandin production and increased
uterine contractility and may cause pre-term labour
[34].
Infection and inflammation account for up to 30% of
preterm deliveries [35] and bacterial vaginosis, the most
commonly associated infection with pre-term delivery, is
more prevalent in pregnant women undergoing greater
psychological stress [36].
These findings highlight the additional complications
a woman and her unborn child may be at risk of as a
result of the increased levels of anxiety associated with
undergoing an invasive genetic test in pregnancy our
observations have shown.
There is an increase in the total fetal attachment score
from a pregnant women’s booking visit to her fetal mor-
phology scan in mid-trimester which many studies have
also reported [24,37,38]. At variance with our observa-
tions, Lawson et al reported that women who opted for
an invasive test had higher levels of attachment than
women at screening or who had no test [19]. However
Table 3 mean total BAI scores for MAAS attachment subscales by group.
Group Total BAI Scores
Booking Group
(Q1) n = 200
Invasive Test
Group (Q2)
n=1 4
Anomaly Scan
Group (Q3)
n=8 1
Maternal total score (global attachment) Low 7.6 (6.9) 10.9 (4.8) 7.7 (7.7)
High 9.1 (8.0) 13.9 (3.9) 8.5 (7.4)
Quality of attachment Negative 9.0 (7.7) 11.9 (4.2) 8.8 (6.8)
Positive 5.0 (4.9) 15.0 (7.1) 6.9 (8.6)
Intensity of Preoccupation Disinterested 7.0 (6.0) 11.0 (5.2) 6.9 (6.1)
Preoccupied 10.2 (8.8) 13.4 (3.9) 9.4 (8.3)
Data are shown as mean (SD).
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correlation between anxiety and attachment, suggesting
that heightened anxiety at the time of an invasive test
may be a cause or consequence of stronger feto-maternal
attachment. This is at variance with some previous stu-
dies that suggest that anxiety leads to a decrease in the
quality of attachment, and that a lack of attachment may
lead to increased anxiety [24,39-41]. Our observation sup-
ports the hypothesis that women who develop an emo-
tional attachment to the fetus are more likely to
experience anxiety about the pregnancy and unborn child
[42,43] and that women who experience low levels of
attachment are likely to feel less anxious about their
pregnancy.
Partners have been shown to experience less anxiety
than their respective partners, supporting previous
research [20,21]. The difference in anxiety between
women and their partners may be explained by the sim-
ple actuality that it is the pregnant woman who is carry-
ing the baby and undergoes any invasive procedure
rather than her partner and is therefore likely to have
additional anxiety related to the pain and possible com-
plications of that procedure.
Study Limitations and Future Work
Considering the potential long-term benefits of under-
going an invasive test in terms of the reduction in anxiety
levels it would be worthwhile undertaking longitudinal
studies of women who have undergone invasive testing
throughout pregnancy and into the postnatal period.
Most previous studies used the Spielberger State-Trait
Anxiety Inventory (STAI) or the Pregnancy-Related
Anxiety Questionnaire (PRAQ-r) to assess anxiety. The
BAI is a widely employed survey instrument that focuses
most on somatic symptoms in order to avoid correlation
with depression as well as anxiety [44]. A study utilising
both the BAI and STAI in adult psychiatric outpatients
found that both scales demonstrated high internal reli-
abilities but that the BAI proved more useful as a screen-
ing instrument for a current anxiety disorder than the
STAI [45,46]. However the BAI gives no indication of a
woman’s underlying ‘trait’ anxiety. Kowalcek et al found
that women who had an increased trait anxiety score
were more likely to have an increased state anxiety score
after an invasive test [47]. The recently developed Beck
A n x i e t yI n v e n t o r y - T r a i t( B A I T )m a yb eau s e f u ls u r v e y
instrument for future research [48]. Although we have
not determined trait anxiety in our cohort of pregnant
women we have tried to minimise the confounding influ-
ence of this on our observation by excluding women with
previous histories of anxiety and depression.
Our pilot data on paternal anxiety and attachment in
relation to invasive prenatal diagnosis should inform lar-
ger sufficiently powered studies aimed at elucidating the
complex factors that are likely to influence feto-paternal
attachment. Furthermore future work exploring the
potential impact of clinical care interventions on mater-
nal anxiety and fetal attachment are needed to optimise
care for this client group.
Conclusion
Women undergoing prenatal diagnostic procedures will
experience more psychological distress and anxiety com-
pared to women who are not at an increased risk of car-
rying a fetus affected by a chromosomal abnormality.
Increased anxiety levels may in turn impact upon the
extent to which a women and her partner can start to
form a bond with their unborn child. It is therefore
important to identify anxiety in pregnancy in order to
offer each woman and her partner the most favourable
environment and opportunities for a healthy pregnancy
and relationship with their child.
The establishment of a multidisciplinary treatment
situation, in which access to psychological support is
offered, may be extremely beneficial for these women
who are at an increased risk of experiencing anxiety.
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